Citius Oncology Inc.CTORNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank67
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-6.01
↑ 87% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-46.53
Historical baseline
PeriodValueYoY Change
2025-6.01-27.7%
2024-4.70+94.2%
2023-80.55+15.1%
2022-94.85-